Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenebrutinib in relapsing multiple sclerosis
PACTR202208658682109Phase 2Unknown
- Sponsor
- Roche
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fenebrutinib, sponsored by Roche. Status: unknown.
02
Drugs
fenebrutinib
Beyond the preview
Go deeper on PACTR202208658682109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208658682109.